Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/Oxaliplatin
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT (NCT01106066) | Samsung Medical Center | 2009-03-01 |
Track Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/Oxaliplatin automatically
Every clearance here is in the API, with alerts when new ones post.